Effect of Upper Limb Ergometer on the AIP in Post Menopausal Obese Women.

NCT ID: NCT04676074

Last Updated: 2021-06-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-11-15

Study Completion Date

2021-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Participants had randomly divided into two equal groups. Group (A) which is the control group receive normal routine medication. Group (B) will receive normal routine medication with the treatment program of moderate intensity upper limb ergometer for 15 minute with frequency three times per week for four weeks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Control group (A):

1. Each participant will sign a consent form after receiving a detailed explanation about the procedure.
2. A blood sample will been taken by a nurse in a heparinized tube and delivered to lab within six hours.
3. BMI will been measured body weight(Kg) and height (m2)

a. BMI= body weight (Kg)/ height (m2).
4. Waist circumference will be measured.
5. After one month blood analysis evaluation will be done to record the response to the routine medication.

Training Procedure for group (B):

1. Each participant will sign a consent form after receiving a detailed explanation about the procedure.
2. A blood sample will been taken by a nurse in a heparinized tube and delivered to lab within six hours.
3. BMI will been measured body weight(Kg) and height (m2)

a. BMI= body weight (Kg)/ height (m2).
4. Waist circumference will be measured.
5. The maximum heart rate will be determined from Tanaka formula (208- 0.7 \*age of the participant)

* Then the exercise load will be determined according heart rate reserve of the participants ( maximum heart rate - resting heart rate).
6. Start with sitting resting without any effort for 5 min then Start at a low speed and intensity for 5 minutes to warm up the body.
7. Increase the speed and intensity for 10-30 seconds before dropping it back for 2-5 minutes and Repeat according to the intensity.
8. Finally, a five minutes of cooling down with no resistance had performed.
9. After one month blood analysis evaluation will be done to record the response to the routine medication.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post Menopausal Obese Women

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants had randomly divided into two equal groups. Group (A) which is the control group receive normal routine medication. Group (B) will receive normal routine medication with the treatment program of moderate intensity upper limb ergometer for 15 minute with frequency three times per week for four weeks.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
Participant

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

the participant will not do any exercise program but just they will take the routine medication.

Group Type NO_INTERVENTION

No interventions assigned to this group

study group

will receive normal routine medication with the treatment program of moderate intensity upper limb ergometer for 15 minute with frequency three times per week for four weeks.

Group Type EXPERIMENTAL

Electronic Upper limb( body) ergometer

Intervention Type DEVICE

Electronic pedal for the upper limb using for training the upper body. Intensity, speed and resistance can be adjusted.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electronic Upper limb( body) ergometer

Electronic pedal for the upper limb using for training the upper body. Intensity, speed and resistance can be adjusted.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* female aged 45-60 years old.
* class 1 and 2 obesity.
* post menopausal.
* diagnosed as controlled diabetic.
* diagnosed as controlled hypertensive.

Exclusion Criteria

* uncontrolled diabetic.
* uncontrolled hypertensive.
* class 3 and morbid obesity.
* mentally unstable person.
* Any shoulder, hand and elbow orthopedic or neural disorders.
Minimum Eligible Age

45 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rana Elbanna

lecturer at faculty of physical therapy at Cairo University

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rana H El Banna, PHD

Role: PRINCIPAL_INVESTIGATOR

Faculty of physical therapy at Cairo University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Outpatient clinic faculty of physical therapy at Cairo University

Giza, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Rana Hesham

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.